Search

everythinglearnresearchcommunity

for

Search:↓

Finger length ratios are not linked to the number of specific gene repeats affecting testosterone sensitivity.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Accurate diagnosis and personalized treatment are crucial for managing women's hair loss.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Baldness may lower the risk of testicular cancer.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

A new compound was made that might help treat diseases related to male hormones.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

Case-only trees and random forests improve predictions of treatment effects in clinical trials.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Reduced AR gene methylation may cause early pubic hair growth in girls.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

Genetic factors and diet significantly increase the risk of male pattern baldness.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

Mediterranean diet with fresh herbs and vegetables lowers male hair loss risk.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Hair loss can indicate brain aging and potential small vessel disease, but more research is needed to understand the clinical impact.

PHAT may improve hair growth better than PRP alone.

MK-R7 supplement with Cistanche Tubulosa and Laminaria Japonica extracts improved hair density and scalp health without adverse effects.

Use minoxidil for hair loss; finasteride and dutasteride for men, dutasteride for women.